Fennec Pharmaceuticals Stock News

Zacks Investment Research lowered shares of Fennec Pharmaceuticals (NASDAQ:FENC) from a buy rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks, Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in []

Fennec Pharmaceuticals (NASDAQ:FENC) had its price objective lowered by Maxim Group from $12.00 to $10.00 in a report released on Wednesday, The Fly reports. The firm currently has a buy rating on the stock. Maxim Groups price target would indicate a potential upside of 135.29% from the stocks previous close. Several other equities analysts have []

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Analysts at Wedbush decreased their Q1 2022 earnings estimates for shares of Fennec Pharmaceuticals in a report issued on Monday, November 29th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.12) for the quarter, down from their previous estimate of $0.02. Wedbush also []

Fennec Pharmaceuticals (NASDAQ:FENC) had its target price cut by Craig Hallum from $19.00 to $14.00 in a report published on Tuesday morning, The Fly reports. They currently have a buy rating on the stock. Separately, Zacks Investment Research upgraded Fennec Pharmaceuticals from a hold rating to a buy rating and set a $11.00 price target []

Fennec Pharmaceuticals (NASDAQ:FENC) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. []

Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading.

Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading.

PHILADELPHIA, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating whether Fennec Pharmaceuticals Inc. (Fennec or the Company) ( NASDAQ: FENC ) violated federal securities laws or engaged in other unlawful business practices.

The stock price of Fennec Pharmaceuticals Inc (NASDAQ: FENC) fell by over 8% during intraday trading today. This is why it happened.

Fennec Pharmaceuticals (NASDAQ:FENC) had its price objective decreased by stock analysts at Craig Hallum from $19.00 to $14.00 in a research note issued to investors on Tuesday, The Fly reports. The firm presently has a buy rating on the stock. Craig Hallums target price would indicate a potential upside of 192.89% from the companys current []

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter (CRL) on

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter (CRL) on November 29, 2021 from the U.S. Food and Drug Administration (FDA), after the PDUFA target action date of November 27, 2021, regarding its New Drug Application (NDA) for PEDMARK (a unique formulation of sodium thiosulfate), for intravenous administration for the prevention of ototoxicity associated with cisplatin chemotherapy in pediatric patients 1 month to 18 years of age with localized, non-metastatic, solid tumors.

NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fennec Pharmaceuticals Inc. (Fennec or the Company) (NASDAQ: FENC). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Adherex Technologies Inc. (FENC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that ma